.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Please enable Javascript to use all features and improve your user experience.

Main Session

Session 2
How microbiomes shape major human diseases and drug availability

Appointment

Date: 11/10/2023

Time: 15:15 – 16:45

Location / Stream:

Chair

Programme

15:15 – 15:45 25 Min. 5 Min.
IT03
Gut microbiome in the development and type 2 diabetes
Prof. Fredrik Bäckhed (Göteburg / SE)
15:45 – 16:15 25 Min. 5 Min.
IT04
The consequences of drugging the gut microbiome - from the individual microbe to the host
Prof. Dr. Lisa Maier (Tübingen / DE)
16:15 – 16:30 10 Min. 5 Min.
Flash Talk
FT03
Impact of the microbiome composition on the fitness of antibiotic resistant mutants
Michael Knopp (Heidelberg / DE)
Microbe-microbe & microbiome-host interaction
16:30 – 16:45 10 Min. 5 Min.
Flash Talk
FT04
Systematic evaluation of long-term drug effects on the gut microbiome in the Estonian Microbiome Cohort
Prof. Elin Org (Tartu / EE)
Microbe-microbe & microbiome-host interaction